2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Tacrolimus Pharmacogenomics: Association of Genetic Variants with Clinical Factors Including Tacrolimus Requirement, Clearance, Intraindividual Variability, and Coefficient Variation.

S.-Y. Kim,¹ J. Oh,² S. Yun,² I.-J. Jang,² S.-I. Min,¹ W. Cho,¹ S. Cho,¹ S. Ahn,¹ S.-K. Min,¹ J. Ha.¹
Tacrolimus Suppresses Calcineurin Activity and Ca2+ Influx Age-Specifically.

F. Krenzien,^1,2 M. Quante,¹ H. Uehara,¹ R. Abdi,¹ H. Cetina Biefer,¹ M. Schmelzle,² J. Pratschke,² A. Elkhal,¹ S. Tullius.¹
Tacrolimus Time in Therapeutic Range Predicts Adverse Clinical Outcomes in the First Year of Kidney Transplant.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

D. Taber, Z. Su, A. Posadas, M. Gebregziabher, L. Egede, D. Dubay, J. McGillicuddy, C. Bratton, S. Nadig, K. Chavin, P. Baliga.
Tangible Benefits in Caregiving Burden Among Spouses/Partners of Transplant Patients: Adding “Donor Benefit” to Live Donor Risk Assessment.

S. Rasmussen, L. Duquette, M. Henderson, D. Segev.
Targeting JAK-STAT Pathways with Tofacitinib Provides a Novel Approach for Conditioning in Allogeneic BMT Recipients.

H. Xu, A. Merchak, M. Xu, C. Mort, T. Dowling, L. Kahn, M. Binion, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.
TB Chemoprophylaxis Post Transplantation in West London.

Y. Al-Mula Abed,¹ R. Charif,² O. Kon,³ D. Taube.²
Technical Characteristics, Optimization and Outcomes of Ultrasound-Guided Biopsy Performed on Kidney Transplant Patients.

J. Juega, M. Perez, L. Cañas, M. Troya, I. Bancu, J. Bonet, R. Lauzurica.
Technical Refinement to Prevent Hepatic Outflow Disturbance in Right Lobe Living Donor Liver Transplantation: Simplified One-Orifice Venoplasty.

J. Kim, D. Choi.
Technically Successful Miniaturization of Blood Hemofilters for an Artificial Kidney via Bioengineering Techniques.

R. Forbes,¹ C. Kensinger,¹ S. Karp,¹ J. Groszek,¹ A. Buck,² D. Colvin,² S. Roy,³ W. Fissell.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z